A: The Commission's independence rules apply to audits of financial statements required by SEC rules, except for those required by Rule 3-05 and 3-14 of Regulation S-X and Item 310(c) and (e) of Regulation S-B.
1 The Centers for Disease Control and Prevention (CDC) recommends 2 doses of quadrivalent meningococcal conjugate vaccine for adolescents 11 through 18 years of age.  The first dose should be given at 11 or 12 years of age, followed by a booster dose at age 16.
Routine immunization with the meningococcal vaccine MCV4 is recommended for children aged 11 or 12, with a booster to be given between ages 16 and 18. Preteens who are 11 and 12 usually have the shot at their 11- or 12-year-old checkup.